Log In
Print
BCIQ
Print
Print this Print this
 

BAL30072

  Manage Alerts
Collapse Summary General Information
Company Basilea Pharmaceutica AG
DescriptionSiderophore sulfactam antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat multidrug-resistant Gram-negative bacterial infections
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today